A New Intraoral Appliance for Trismus in Oral Submucous Fibrosis

Trismus is the most common sequelae of various pathological processes leading to compromised nutritional state in addition to physical and psychological disabilities. Therapeutic interventions are available to relieve trismus, which range from oral usage of pharmacological agents to intralesional st...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in dentistry Vol. 2018; no. 2018; pp. 1 - 5
Main Authors: Badam, Rajkumar, Suvarna, Chintada, Nithika, Madireddy, Priyanka Danam, Reshma, Krishna Prasad, C. M. S., Chaitanya, Nallan C. S. K., Nancypriyanka, Jampala
Format: Journal Article
Language:English
Published: Cairo, Egypt Hindawi Publishing Corporation 01-01-2018
Hindawi
John Wiley & Sons, Inc
Hindawi Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Trismus is the most common sequelae of various pathological processes leading to compromised nutritional state in addition to physical and psychological disabilities. Therapeutic interventions are available to relieve trismus, which range from oral usage of pharmacological agents to intralesional steroid therapy. Intraoral appliance therapy can be employed as an alternative or adjuvant treatment for radiotherapy-induced fibrosis and autoimmune disorders such as scleroderma, psychogenic trismus, and oral submucous fibrosis, decreasing the adverse effects associated with other pharmacological interventions. A novel intraoral appliance—“Nallan C-H”—has been developed and tried for trismus producing better results. A report on three such cases having trismus due to a premalignancy has been presented. It is hypothesized that the same appliance can be used for treating inoperable trismus in palliative care setting additionally or as an adjuvant to pharmacological approach.
Bibliography:Academic Editor: Tommaso Lombardi
ISSN:2090-6447
2090-6455
DOI:10.1155/2018/1039391